Remission and Dropout Rate of Anti-VEGF Therapy for Age-Related Macular Degeneration

Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials

(2009) P Mitchell et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Exudative AMD subtypes and eligibility for treatment with ranibizumab

(2009) S George et al.   EYE

Antiangiogenic Approaches to Age-Related Macular Degeneration Today

(2009) Neil M. Bressler   OPHTHALMOLOGY

Evaluation of Injection Frequency and Visual Acuity Outcomes for Ranibizumab Monotherapy in Exudative Age-related Macular Degeneration

(2009) Hajir Dadgostar et al.   OPHTHALMOLOGY

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

(2008) Carl D. Regillo et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

(2008) David M. Brown et al.   OPHTHALMOLOGY

Comparison of Visual Acuity in Macular Degeneration Patients Measured with Snellen and Early Treatment Diabetic Retinopathy Study Charts

(2007) Iryna A. Falkenstein et al.   OPHTHALMOLOGY